All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| VECT / VectivBio Holding AG
|
|
|
|
|
|
|
|
| AVIR / Atea Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|
| AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| LIANY / LianBio - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
| EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
| ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
| CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ERAS / Erasca, Inc.
|
|
|
|
|
|
|
|
| LBPH / Longboard Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
| GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
| ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| IMRX / Immuneering Corporation
|
|
|
|
|
|
|
|
| ALT / Altimmune, Inc.
|
|
|
|
|
|
|
|
| ALT / Altimmune, Inc. Call
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
| BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
| ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| ETNB / 89bio, Inc.
|
|
|
|
|
|
|
|
| ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
| RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
|
|
|
|
|
| MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
| TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ANNX / Annexon, Inc.
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US39536G1058 / GREENLIGHT BIOSCIENCES HOLDINGS PBC A
|
|
|
|
|
|
|
|
| PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ICVX / Icosavax, Inc.
|
|
|
|
|
|
|
|
| VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PCVX / Vaxcyte, Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LPTX / Leap Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PSTX / Poseida Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLTO / Galecto, Inc.
|
|
|
|
|
|
|
|
| COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
| HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VIGL / Vigil Neuroscience, Inc.
|
|
|
|
|
|
|
|
| TALS / Talaris Therapeutics Inc
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
| BMEA / Biomea Fusion, Inc.
|
|
|
|
|
|
|
|
| PHVS / Pharvaris N.V.
|
|
|
|
|
|
|
|
| STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GHRS / GH Research PLC
|
|
|
|
|
|
|
|
| ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
| VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AMAM / Ambrx Biopharma Inc.
|
|
|
|
|
|
|
|
| TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
